pentobarbital has been researched along with Irritable Bowel Syndrome in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
STEGGERDA, FR | 1 |
RICHARDS, RK | 1 |
HOEKSTRA, J | 1 |
1 other study available for pentobarbital and Irritable Bowel Syndrome
Article | Year |
---|---|
Observations on the synergistic effects of various antispasmodic compounds and nembutal on colon activity in normal adult males.
Topics: Adult; Barbital; Colon; Humans; Irritable Bowel Syndrome; Male; Parasympatholytics; Pentobarbital; S | 1946 |